Efficacy of α-blocker or 5-ARI Withdrawal to Continued Combination Therapy on the Maintenance of LUTS in Men With BPH
Status:
Recruiting
Trial end date:
2023-12-07
Target enrollment:
Participant gender:
Summary
The investigators compare the efficacy of alpha-blocker and 5-ARI withdrawal to continued
combination therapy on the maintenance of LUTS and improvement of quality of life outcomes in
men with benign prostatic hyperplasia.